Search by Drug Name or NDC

    NDC 28595-0804-16 HISTEX-DM 20; 10; 2.5 mg/5mL; mg/5mL; mg/5mL Details

    HISTEX-DM 20; 10; 2.5 mg/5mL; mg/5mL; mg/5mL

    HISTEX-DM is a ORAL SYRUP in the HUMAN OTC DRUG category. It is labeled and distributed by Allegis Pharmaceuticals, LLC. The primary component is DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE.

    Product Information

    NDC 28595-0804
    Product ID 28595-804_0e764fe3-cd4a-71c8-e063-6394a90afa31
    Associated GPIs 43995803961220
    GCN Sequence Number 072192
    GCN Sequence Number Description triprolidine/phenylephrine/DM LIQUID 2.5-10-20 ORAL
    HIC3 B3R
    HIC3 Description NON-OPIOID ANTITUS-1ST GEN.ANTIHISTAMINE-DECONGEST
    GCN 36311
    HICL Sequence Number 041030
    HICL Sequence Number Description TRIPROLIDINE HCL/PHENYLEPHRINE HCL/DEXTROMETHORPHAN HBR
    Brand/Generic Brand
    Proprietary Name HISTEX-DM
    Proprietary Name Suffix n/a
    Non-Proprietary Name DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE, and TRIPROLIDINE HYDROCHLORIDE
    Product Type HUMAN OTC DRUG
    Dosage Form SYRUP
    Route ORAL
    Active Ingredient Strength 20; 10; 2.5
    Active Ingredient Units mg/5mL; mg/5mL; mg/5mL
    Substance Name DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE
    Labeler Name Allegis Pharmaceuticals, LLC
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH DRUG
    Application Number M012
    Listing Certified Through 2025-12-31

    Package

    NDC 28595-0804-16 (28595080416)

    NDC Package Code 28595-804-16
    Billing NDC 28595080416
    Package 473 mL in 1 BOTTLE (28595-804-16)
    Marketing Start Date 2014-03-19
    NDC Exclude Flag N
    Pricing Information N/A